Minimization—reducing predictability for multi‐centre trials whilst retaining balance within centre
Sarah Brown(University of Leeds), Julia Brown(University of Leeds), Kim Hawkins(University of Leeds), H. Thorpe(University of Leeds)
Cited by 102
Related Papers
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
|New England Journal of Medicine|2003|1.8k
Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial
|The Lancet|2010|640
Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial
|The Lancet|2015|477
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
|The Lancet Oncology|2013|392
Clinical development of new drug–radiotherapy combinations
|Nature Reviews Clinical Oncology|2016|317